Thromboxane prostanoid signaling in macrophages attenuates lymphedema and facilitates lymphangiogenesis in mice
Molecular Biology Reports · 2023
DOI: 10.1007/s11033-023-08620-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2023. Verfasst von Toshiaki Mishima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: Lymphatic Vessels, Lymphedema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Background
Accumulating evidence suggests that prostaglandin E 2 , an arachidonic acid (AA) metabolite, enhances lymphangiogenesis in response to inflammation. However, thromboxane A 2 (TXA 2 ), another AA metabolite, is not well known. Thus, this study aimed to determine the role of thromboxane prostanoid (TP) signaling in lymphangiogenesis in secondary lymphedema. Methods and results Lymphedema was induced by the ablation of lymphatic vessels in mouse tails. Compared with wild-type mice, tail lymphedema in Tp -deficient mice was enhanced, which was associated with suppressed lymphangiogenesis as indicated by decreased lymphatic vessel area and pro-lymphangiogenesis-stimulating factors. Numerous macrophages were found in the tail tissues of Tp -deficient mice. Furthermore, the deletion of TP in macrophages increased tail edema and decreased lymphangiogenesis and pro-lymphangiogenic cytokines, which was accompanied by increased numbers of macrophages and gene expression related to a pro-inflammatory macrophage phenotype in tail tissues. In vivo microscopic studies revealed fluorescent dye leakage in the lymphatic vessels in the wounded tissues.
Conclusions
The results suggest that TP signaling in macrophages promotes lymphangiogenesis and prevents tail lymphedema. TP signaling may be a therapeutic target for improving lymphedema-related symptoms by enhancing lymphangiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
- Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa, 252-0374, Japan.
- Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa, 252-0374, Japan.
- Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa, 252-0374, Japan. yito@kitasato-u.ac.jp.
- Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa, 252-0374, Japan. yito@kitasato-u.ac.jp.
- Department of Pharmacology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. yito@kitasato-u.ac.jp.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Mishima, T., Hosono, K., Tanabe, M., Ito, Y., Majima, M., Narumiya, S., Miyaji, K., & Amano, H. (2023). Thromboxane prostanoid signaling in macrophages attenuates lymphedema and facilitates lymphangiogenesis in mice. Molecular Biology Reports. https://doi.org/10.1007/s11033-023-08620-0
Vancouver
Mishima T, Hosono K, Tanabe M, Ito Y, Majima M, Narumiya S, et al. Thromboxane prostanoid signaling in macrophages attenuates lymphedema and facilitates lymphangiogenesis in mice. Molecular Biology Reports. 2023. doi:10.1007/s11033-023-08620-0
BibTeX
@article{Mishima2023,
author = {Mishima, Toshiaki and Hosono, Kanako and Tanabe, Mina and Ito, Yoshiya and Majima, Masataka and Narumiya, Shuh and Miyaji, Kagami and Amano, Hideki},
title = {Thromboxane prostanoid signaling in macrophages attenuates lymphedema and facilitates lymphangiogenesis in mice},
journal = {Molecular Biology Reports},
year = {2023},
doi = {10.1007/s11033-023-08620-0}
}
EUVIMED